First Eagle Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
First Eagle Investment Management's BMY Position: Q1 2018 in Review
First Eagle Investment Management sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 49,229 shares — an estimated $3.02M sold.
First Eagle Investment Management first reported a position in BMY in Q2 2013 and held it in 19 quarters. The position peaked at $3.14M in Q3 2017. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.
- First Eagle Investment Management reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
- First Eagle Investment Management sold 49,229 Bristol-Myers Squibb shares in Q1 2018, an estimated $3.02M.
- First Eagle Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 19 quarters.
- First Eagle Investment Management's Bristol-Myers Squibb position peaked at $3.14M in Q3 2017.
- 1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.
Based on First Eagle Investment Management's 13F filing for Q1 2018, filed 4 May 2018.